| |
| |
|
| Insider
Information: |
Cheng Andrew |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
589,447 |
|
|
Indirect Shares
|
17,488 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
606,935 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
589,447 |
|
0 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-18 |
0 |
2021-05-18 |
17,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
325,289 |
|
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2019-12-31 |
4 |
A |
$18.87 |
$19,338 |
D/D |
1,025 |
326,314 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-06-30 |
4 |
A |
$17.07 |
$21,250 |
D/D |
1,245 |
327,559 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
50 |
327,509 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
325,009 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-21 |
4 |
OE |
$0.62 |
$6,510 |
D/D |
10,500 |
335,509 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-28 |
4 |
OE |
$0.62 |
$4,638 |
D/D |
7,480 |
342,989 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2020-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
359,989 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-07 |
4 |
OE |
$0.62 |
$12,300 |
D/D |
20,000 |
362,989 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-01-10 |
4 |
AS |
$19.55 |
$195,500 |
D/D |
(10,000) |
298,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-07-02 |
4 |
AS |
$24.78 |
$433,650 |
D/D |
(17,500) |
342,489 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-08-03 |
4 |
AS |
$20.81 |
$364,577 |
D/D |
(17,500) |
325,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-09-02 |
4 |
AS |
$23.89 |
$418,075 |
D/D |
(17,500) |
308,496 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-10-04 |
4 |
AS |
$21.54 |
$376,950 |
D/D |
(17,500) |
290,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-11-02 |
4 |
AS |
$22.57 |
$394,975 |
D/D |
(17,500) |
273,496 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2021-12-02 |
4 |
AS |
$20.18 |
$353,150 |
D/D |
(17,500) |
255,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-01-03 |
4 |
OE |
$0.62 |
$32,595 |
D/D |
53,000 |
308,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-01-10 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
308,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-02-01 |
4 |
AS |
$17.56 |
$175,600 |
D/D |
(10,000) |
308,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-02-01 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
318,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-03-01 |
4 |
OE |
$0.62 |
$6,150 |
D/D |
10,000 |
318,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-03-01 |
4 |
AS |
$17.59 |
$175,900 |
D/D |
(10,000) |
308,996 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President and CEO |
• • – |
2022-06-30 |
4 |
A |
$8.03 |
$9,251 |
D/D |
1,152 |
310,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-09-13 |
4 |
AS |
$26.74 |
$1,645,444 |
D/D |
(60,000) |
310,148 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
President & CEO |
• • – |
2022-09-13 |
4 |
OE |
$0.62 |
$36,900 |
D/D |
60,000 |
370,148 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
